Tolcapone, a Selective Catechol-O-Methyltransferase Inhibitor for Treatment of Parkinson’s Disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tolcapone, a Selective Catechol-O-Methyltransferase Inhibitor for Treatment of Parkinson’s Disease

Published:1999-01 Issue:1 Volume:19 Page:6-20
ISSN:0277-0008
Container-title:Pharmacotherapy
language:en
Short-container-title:Pharmacotherapy

Author:

Guay David R. P.

Publisher

Wiley

Subject

Pharmacology (medical)

Reference58 articles.

1. Rationale for Selective COMT Inhibitors as Adjuncts in the Drug Treatment of Parkinson's Disease

2. Improved Therapy of Parkinsonʼs Disease with Tolcapone, a Central and Peripheral COMT Inhibitor with an S-Adenosyl-L-Methionine-Sparing Effect

3. Catechol‐O‐methyltransferase inhibition increases striatal L‐dopa and dopamine

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effectiveness and safety of different catechol-o-methyl transferase inhibitors for patients with parkinson’s disease: Systematic review and network meta-analysis;Clinical Neurology and Neurosurgery;2024-04

2. A systematic review of the cognitive effects of the COMT inhibitor, tolcapone, in adult humans;CNS Spectrums;2024-03-15

3. Palladium‐Catalyzed Oxidative Carbonylation of Diarylamines for the Synthesis of Acridone Derivatives;Asian Journal of Organic Chemistry;2023-12-27

4. Recent progress in fluorescent probes for transthyretin sensing;Dyes and Pigments;2023-12

5. Unraveling the impact of 27-hydroxycholesterol in autoimmune diseases: Exploring promising therapeutic approaches;Pathology - Research and Practice;2023-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3